Fungal-derived supplements in integrative oncology

Area of Science:

• Integrative Oncology
• Pharmacology
• Mycology

Background:

• Growing interest in fungal-derived supplements for cancer patient support.
• Preclinical and clinical studies suggest immunomodulatory, neuroprotective, and antioxidant effects of fungi.
• Limited integration of these natural approaches in current cancer care practices.

Purpose of the Study:

• To highlight the potential benefits of fungal supplements in cancer patient care.
• To encourage greater investigation into the use of fungi as complementary therapies.
• To promote the integration of fungal-derived supplements within an integrative medicine framework.

Main Methods:

• Review of preclinical animal studies on fungal activities.
• Analysis of human clinical studies supporting fungal benefits.
• Compilation of examples demonstrating positive patient well-being impacts.

Main Results:

• Fungal supplements exhibit significant immunomodulatory, neuroprotective, and antioxidant properties.
• Evidence from both animal and human studies supports these therapeutic potentials.
• Documented cases show positive contributions to patients' overall well-being.

Conclusions:

• Fungal-derived supplements offer a promising avenue for enhancing cancer patient care.
• There is a need for increased healthcare professional utilization and investigation of these natural products.
• Integrating fungal supplements into cancer treatment plans can support patient well-being.